Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib + Toripalimab + Albumin-bound Paclitaxel in Advanced Pancreatic Cancer
NCT07040228Phase 2Recruiting
- Start
- May 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regorafenib in pancreatic cancer (PC). Started May 2025; status: recruiting.
02
Drugs
regorafenib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07040228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07040228.